Alzheimer's mechanisms in ischemic brain degeneration

Anatomical Record

Volumn 292, Issue 12, 2009, Pages 1863-1881

  Pluta, Ryszard ^a   Ułamek, Marzena ^a   Jabłoński, Mirosław ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

, , secretases; synuclein; amyloid peptide; Alzheimer's disease; Amyloid precursor protein; Apolipoproteins; Brain ischemia; Inflammation; Presenilins; Tau protein

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; BETA SECRETASE; CASPASE 11; CASPASE 3; CASPASE 9; CLUSTERIN; GELATINASE B; HEAT SHOCK PROTEIN; INTERLEUKIN 1BETA; LEUKOTRIENE C4; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MIDKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PRESENILIN; REACTIVE OXYGEN METABOLITE; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACTIVE IMMUNIZATION; AGING; ALZHEIMER DISEASE; ARACHIDONIC ACID METABOLISM; BLOOD BRAIN BARRIER; BRAIN DEGENERATION; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CONFERENCE PAPER; DNA DAMAGE; GENE EXPRESSION; GENE THERAPY; HIPPOCAMPUS; HUMAN; MEMORY DISORDER; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN METABOLISM; SURVIVAL TIME; TAUOPATHY; UPREGULATION; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; ENCEPHALITIS; HUMANS; INFLAMMATION MEDIATORS; NERVE DEGENERATION; TAU PROTEINS;

EID: 73849150146     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21018     Document Type: Conference Paper

References (212)

1. Abe K, Tanzi RE, Kogure K. 1991. Selective induction of Kunitztype protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci Lett 125:172-174.
2. Adhami F, Schloemer A, Kuan CY. 2007. The roles of autophagy in cerebral ischemia. Autophagy 3:42-44.
3. Adibhatla RM, Hatcher JF, Larson EC, Chen X, Sun D, Tsao FH. 2006. CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke. J Biol Chem 281:6718-6725.
4. Ali SM, Dunn E, Oostveen JA, Hall ED, Carter DB. 1996. Induction of apolipoprotein E mRNA in the hippocampus of the gerbil after transient global ischemia. Mol Brain Res 38:37-44.
5. Anfuso CD, Assero G, Lupo G, Nicota A, Cannavo G, Strosznajder RP, Rapisarda P, Pluta R, Alberghina M. 2004. Amyloid beta (1-42) and its beta (25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A (2) in bovine retina capillary pericytes. Biochem Biophys Acta 1686:125-138.
6. Badan I, Dinca I, Buchhold B, Suofu Y, Walker L, Gratz M, Platt D, Kessler CH, Popa-Wagner A. 2004. Accelerated accumulation of N- and C-terminal beta APP fragments and delayed recovery of microtubule-associated protein 1B expression following stroke in aged rats. Eur J Neurosci 19:2270-2280.
7. Badan I, Platt D, Kessler C, Popa-Wagner A. 2003. Temporal dynamics of degenerative and regenerative events associated with cerebral ischemia in aged rats. Gerontology 49:356-365.
8. Badin RA, Lythgoe MF, Van der Weerd L, Thomas DL, Gadian DG, Latchman DS. 2006. Neuroprotective effects of virally delivered HSPs in experimental stroke. J Cereb Blood Flow Metab 26: 371-381.
9. Banati RB, Gehrmann J, Wießner C, Hossmann KA, Kreutzberg GW. 1995. Glial expression of the β-amyloid precursor protein (APP) in global ischemia. J Cereb Blood Flow Metab 15: 647-654.
10. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ. 1997. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233-1244.
11. Bell RD, Deane R, Chow N, Long X, Sagare A, Singh I, Streb JW, Guo H, Rubio A, Van Nostrand W, Miano JM, Zlokovic BV. 2009. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat Cell Biol 11:143-153.
12. Beschorner R, Schluesener HJ, Gonzalan F, Meyermann R, Schwab JM. 2002. Infiltrating CD14+ monocytes and expession of CD14 by activated parenchymal microglia/macrophages contribute to the pool of CD14+ cells in ischemic brain lesions. J Neuroimmunol 126:107-115.
13. Block F. 1999. Global ischemia and behavioural deficits. Prog Neurobiol 58:279-295.
14. Block F, Schwarz M. 1998. Global ischemic neuronal damage relates to behavioural deficits: a pharmacological approach. Neuroscience 82:791-803.
15. Boje KM, Arora PK. 1992. Microglial-produced nitric oxide and reactive nitrogen-oxides mediate neuronal cell-death. Brain Res 587:250-256.
16. Buttini M, Sauter A, Boddeke HW. 1994. Induction of interleukin-1 beta mRNA after focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 23:126-134.
17. Cao YJ, Shibata T, Rainov NG. 2002. Liposome-mediated transfer of the bcl-2 gene results in neuroprotection after in vivo transient focal cerebral ischemia in an animal model. Gene Ther 9:415-419.
18. Che X, Ye W, Panga L, Wu DC, Yang GY. 2001. Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res 902:171-177.
19. Chen PH. 2001. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2-14.
20. Chen Y, Hallenbeck JM, Ruetzler C, Bol D, Thomas K, Berman NE, Vogel SN. 2003. Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab 23:748-755.
21. Chuang CM, Hsieh CL, Lin HY, Lin JG. 2008. Panax Notoginseng Burk attenuates impairment of learning and memory functions and increases ED1, BDNF and beta-secretase immunoreactive cells in chronic stage ischemia-reperfusion injured rats. Am J Chin Med 36:685-693.
22. Colbourne F, Corbett D. 1995. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci 15:7250-7260.
23. Cotter RL, Burke WJ, Thomas VS, Potter JF, Zheng J, Gendelman HE. 1999. Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity. J Leukocyte Biol 65:416-427.
24. Cui J, Holmes EH, Greene TG, Liu PK. 2000. Oxidative DNA damage precedes DNA fragmentation after experimental stroke in rat brain. FASEB J 14:955-967.
25. Davies CA, Loddick SA, Toulmond S, Stroemer RP, Hunt J, Rothwell NJ. 1999. The progression and topographic distribution of interleukin-1 beta expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 19:87-98.
26. Davis HP, Tribuna J, Pulsinelli WA, Volpe BT. 1986. Reference and working memory of rats following hippocampal damage induced by transient forebrain ischemia. Physiol Behav 37:387-392.
27. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitachison TJ, Moskowitz MA, Yuan J. 2005. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112-119.
28. De la Torre JC. 2002. Vascular basis of Alzheimer's pathogenesis. Ann NY Acad Sci 977:196-215.
29. Dewar D, Dawson D. 1995. Tau protein is altered by focal cerebral ischaemia in the rat: an immunohistochemical and immunoblotting study. Brain Res 6 84:70-78.
30. Dewar D, Graham DI, Teasdale GM, McCulloch J. 1993. Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat. Acta Neuropathol 86:623-629.
31. Dewar D, Graham DI, Teasdale GM, McCulloch J. 1994. Cerebral ischemia induces alterations in tau and ubiquitin proteins. Dementia 5:168-173.
32. Dickstein DL, Biron KE, Ujiie M, Pfeifer CG, Jeffries AR, Jefferies WA. 2006. Aβ peptide immunization restores blood-brain barrier integrity in Alzheimer disease. FASEB J 20:426-433.
33. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36:180-190.
34. Dong Z, Saikumar P, Weinberg JM, Venkatachalam MA. 1997. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases. Am J Pathol 151:1205-1213.
35. Donohue PJ, Richards CM, Brown SA, Hanscom HN, Buschman J, Thangada S, Hla T, Williams MS, Winkles JA. 2003. TWEAK is an endothelial cell growth and chemotactic factor that also potentates FGF-2 and VEGF-A mitogenic activity. Arterioscler Thromb Vasc Biol 23:594-600.
36. Emsley HC, Tyrrell PJ. 2002. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 22:1399-1419.
37. Endoh M, Maiese K, Wagner J. 1994. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res 651:92-100.
38. Fujioka M, Taoka T, Matsuo Y, Mishima K, Ogoshi K, Kondo Y, Isuda M, Fujiwara M, Asano T, Sakaki T, Miyasaki A, Park D, Siesjo BK. 2003. Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration. Ann Neurol 54: 732-747.
39. Fujimura M, Morita-Fujimura Y, Murakami K, Kawase M, Chan PH. 1998. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 18:1239-1247.
40. Fukuchi K, Ho L, Younkin SG, Kunkel DD, Ogburn CE, LeBoeuf RC, Furlong CE, Deeb SS, Nochlin D, Wegiel J, Wisniewski HM, Martin GM. 1996. High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice. Am J Pathol 149:219-227.
41. Garau A, Bertini R, Colotta F, Casilli F, Bigini P, Cagnotto A, Mennini T, Ghezzi P, Villa P. 2005. Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia. Cytokine 30:125-131.
42. Geddes JW, Schwab C, Craddock S, Wilson JL, Pettigrew LC. 1994. Alterations in tau immunostaining in the rat hippocampus following transient cerebral ischemia. J Cereb Blood Flow Metab 14:554-564.
43. Gehrmann J, Bonnekoh P, Miyazawa T, Hossmann KA, Kreutzberg G. 1992. Immunocytochemical study of early microglial activation in ischemia. J Cereb Blood Flow Metab 12:257-269.
44. Giffard RG, Swanson RA. 2005. Ischemia-induced programmed cell death in astrocytes. Glia 50:299-306.
45. Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D, Li X, Kirkpatrick JB. 1995. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 27:119-137.
46. Goedert M. 2001. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2:492-501.
47. Gorelick PB. 1997. Status of risk factors for dementia associated with stroke. Stroke 28:459-463.
48. Griffin WS, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE. 1998. Glial-neuronal interactions in Alzheimer's disease: the potential role of a "Cytokine Cycle" in disease progression. Brain Pathol 8:65-72.
49. Guo JT, Yu J, Grass D, De Beer FC, Kindy MS. 2002. Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci 22:5900-5909.
50. Hagberg H, Wilson MA, Matsushita H, Zhu C, Lange M, Gustavsson M, Poitras MF, Dawson TM, Dawson VL, Northington F, Johnston MV. 2004. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem 90:1068-1075.
51. Hall ED, Oostveen JA, Dunn E, Carter DB. 1995. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol 135:17-27.
52. Han HS, Yenari MA. 2003. Cellular targets of brain inflammation in stroke. Curr Opin Investig Drugs 4:522-529.
53. Haqqani AS, Nesic M, Preston E, Baumann E, Kelly J, Stanimirovic D. 2005. Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB J 19:1809-1821.
54. Hashimoto M, Masliah E. 1999. Alpha-synuclein in Lewy body disease and Alzheimer's disease. Brain Pathol 9:707-720.
55. Heneka MT, Loschmann PA, Gleichmann M, Weller M, Schultz JB, Wullner U, Klockgether T. 1998. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J Neurochem 71:88-94.
56. Heneka MT, Wiesinger H, Dumitrescu-Ozimek L, Riederer P, Feinstein DL, Klockgether T. 2001. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol 60:906-916.
57. Heneka MT, O'Banion MK. 2007. Inflammatory processes in Alzheimer's disease. J Neuroimmunol 184:69-91.
58. Hillis AE. 2006. Neurobiology of unilateral spatial neglect. Neuroscientist 12:119-126.
59. Hoozemans JJ, Veerhuis R, Rozemuller AJ, Arendt T, Eikelenboom P. 2004. Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex. Neurobiol Dis 25:492-499.
60. Horsburgh K, Nicoll JAR. 1996a. Selective cellular alterations in amyloid precursor protein and apolipoprotein E following transient cerebral ischaemia in the rat. Alzheimer Res 2:37-42.
61. Horsburgh K, Nicoll JAR. 1996b. Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischemia in the rat. Neuropathol Appl Neurobiol 22:342-349.
62. Huang D, Shenoy A, Cui J, Huang W, Liu PK. 2000. In situ detection of AP sites and DNA strand breaks bearing 3′-phosphate termini in ischemic mouse brain. FASEB J 14:407-417.
63. Hurn PD, Brass LM. 2003. Estrogen and stroke: a balanced analysis. Stroke 34:338-341.
64. Hurn PD, Vannucci SJ, Hagberg H. 2005. Adult or perinatal brain injury: does sex matter? Stroke 36:193-195.
65. Irving EA, Yatsushiro K, McCulloch J, Dewar D. 1997. Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals. J Cereb Blood Flow Metab 17:612-622.
66. Ishibashi S, Kuroiwa T, LiYuan S, Katsumata N, Li S, Endo S, Mizusawa H. 2006. Long-term cognitive and neuropsychological symptoms after global cerebral ischemia in Mongolian gerbils. Acta Neurochir (Suppl) 96:299-302.
67. Ishimaru H, Ishikawa K, Haga S, Shoji M, Ohe Y, Haga C, Sasaki A, Takahashi A, Maruyama Y. 1996a. Accumulation of apolipoprotein E and β-amyloid-like protein in a trace of the hippocampal CA1 pyramidal cell layer after ischaemic delayed neuronal death. NeuroReport 7:3063-3067.
68. Ishimaru H, Ishikawa K, Ohe Y, Takahashi A, Maruyama Y. 1996b. Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus. Brain Res 709:155-162.
69. Ishimaru H, Ueda K, Takahashi A, Maruyama Y. 1998. Changes in presynaptic protein NACP/alpha-synuclein in an ischemic gerbil hippocampus. Brain Res 788:311-314.
70. Jendroska K, Poewe W, Daniel SE, Pluess J, Iwerssen-Schmidt H, Paulsen J, Barthel S, Schelosky L, Cervos-Navarro J, DeArmond SJ. 1995. Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuropathol 90:461-466.
71. Ji ZS, Miranda RD, Newhouse YM, Weisgraber KH, Huang Y, Mahley RW. 2002. Apolipoprotein E4 potentiates amyloid b peptideinduced lysosomal leakage and apoptosis in neuronal cells. J Biol Chem 277:21821-21828.
72. Kamada H, Sato K, Zhang WR, Omori N, Nagano I, Shoji M, Abe K. 2003. Spatiotemporal changes of apolipoprotein E immunoreactivity and apolipoprotein E mRNA expression after transient middle cerebral artery occlusion in rat brain. J Neurosci Res 73:545-556.
73. Karasawa Y, Araki H, Otomo S. 1994. Changes in locomotor activity and passive avoidance task performance induced by cerebral ischemia in mongolian gerbils. Stroke 25:645-650.
74. Karhunen H, Pitkanen A, Virtanen T, Gureviciene I, Pussinen R, Ylinen A, Sivenius J, Nissinen J, Jolkkonen J. 2003. Long-term functional consequences of transient occlusion of the middle cerebral artery in rats: a 1-year follow-up of the development of epileptogenesis and memory impairment in relation to sensorimotor deficits. Epilepsy Res 54:1-10.
75. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C. 2006. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12: 225-229.
76. Kelly MA, Shuaib A, Todd KG. 2006. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis. Exp Neurol 200:38-49.
77. Kida E, Pluta R, Lossinsky AS, Golabek AA, Choi-Miura NH, Wisniewski HM, Mossakowski MJ. 1995. Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain. Brain Res 674:341-346.
78. Kim HS, Lee SH, Kim SS, Kim YK, Jeong SJ, Ma J, Han DH, Cho BK, Suh YH. 1998. Post-ischemic changes in the expression of Alzheimer's APP isoforms in rat cerebral cortex. NeuroReport 9:533-537.
79. Kim YD, Sohn NW, Kang C, Soh Y. 2002. DNA array reveals altered gene expression in response to focal cerebral ischemia. Brain Res Bull 58:491-498.
80. Kirino T. 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239:57-69.
81. Kitamura Y, Ishida Y, Takata K, Kakimura J, Mizutani H, Shimohama S, Akaike A, Taniguchi T. 2001. Alpha-synuclein protein is not scavenged in neuronal loss induced by kainic acid or focal ischemia. Brain Res 898:181-185.
82. Kiyota Y, Miyamoto M, Nagaoka A. 1991. Relationship between brain damage and memory impairment in rats exposed to transient forebrain ischemia. Brain Res 538:295-302.
83. Koistinaho J, Hökfelt T. 1997. Altered gene expression in brain ischemia. NeuroReport 8:I-VIII.
84. Koistinaho J, Pyykönen I, Keinänen R, Hökfelt T. 1996. Expression of β-amyloid precursor protein mRNAs following transient focal ischaemia. NeuroReport 7:2727-2731.
85. Koistinaho M, Kettunen MI, Goldsteins G, Keinanen R, Salminen A, Ort M, Bures J, Liu D, Kauppinen RA, Higgins LS, Koistinaho J. 2002. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc Natl Acad Sci USA 99:1610-1615.
86. Kuroiwa T, Bonnekoh P, Hossmann KA. 1991. Locomotor hyperactivity and hippocampal CA1 injury after transient forebrain ischemia in gerbils. Neurosci Lett 122:141-144.
87. Lenhnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T. 2003. Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA 100:8514-8519.
88. Li GZ, Zhong D, Yang LM, Sun B, Zhong ZH, Yin YH, Cheng J, Yan BB, Li HL. 2005. Expression of interleukin-17 in ischemic brain tissue. Scand J Immunol 62:481-486.
89. Lin B, Ginsberg MD, Busto R. 2001. Hyperglycemic but not normoglycemic global ischemia induces marked early intraneuronal expression of β-amyloid precursor protein. Brain Res 888: 107-116.
90. Lin B, Schmidt-Kastner R, Busto R, Ginsberg MD. 1999. Progressive parenchymal deposition of β-amyloid precursor protein in rat brain following global cerebral ischemia. Acta Neuropathol 97:359-368.
91. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ. 1994. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25:1481-1488.
92. Loeb C, Gandolfo C, Bino G. 1988. Intellectual impairment and cerebral lesions in multiple cerebral infarcts: a clinical-computed tomography study. Stroke 19:560-565.
93. Lu XC, Willliams AJ, Yao C, Berti R, Hartings JA, Whipple R, Vahey MT, Polavarapu RG, Woller KL, Tortella FC, Dave JR. 2004. Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J Neurosci Res 77:843-857.
94. Lupo G, Anfuso CD, Assero G, Strosznajder RP, Walski M, Pluta R, Alberghina M. 2001. Amyloid β (1-42) and its β (25-35) fragment induce in vitro phosphatidylcholine hydrolysis in bovine retina capillary pericytes. Neurosci Lett 303:185-188.
95. Mailliot C, Podevin-Dimster V, Rosenthal RE, Sergeant N, Delacourte A, Fiskum G, Buee L. 2000. Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrestinduced cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 20:543-549.
96. Malm T, Koistinaho M. 2007. Relationships between brain ischemia and Alzheimer's disease-insights derived from preclinical animal models. In: Pluta R, editor. Ischemia-reperfusion pathways in Alzheimer's disease. New York: Nova Science Publishers. p 17-39.
97. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, Krammer PH. 2001. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 8:679-686.
98. Mattson MP, Zhu HY, Yu J, Kindy MS. 2000. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J Neurosci 20:1358-1364.
99. McCullough LD, Hurn PD. 2003. Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol Metab 14:228-235.
100. Mileson BE, Schwartz RD. 1991. The use of locomotor activity as a behavioral screen for neuronal damage following transient forebrain ischemia in gerbils. Neurosci Lett 128:71-76.
101. Mori T, Tateishi N, Kagamiishi Y, Shimoda T, Satoh S, Ono S, Katsube N, Asano T. 2004. Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent ONO-2506 96. Neurochem Int 45:381-387.
102. Morioka T, Kalehua AN, Streit WJ. 1992. Progressive expression of immunomolecules on microglial cells in rat dorsal hippocampus following transient forebrain ischemia. Acta Neuropathol 83: 149-157.
103. Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA. 2003. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 140:471-476.
104. Murakami Y, Saito K, Hara A, Zhu Y, Sudo K, Niwa M, Fujii H, Wada H, Ishiguro H, Mori H, Seishima M. 2005. Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neurons death in mouse hippocampus. J Neurochem 93:1616-1622.
105. Muralikrishna Adibhatla R, Hatcher JF. 2006. Phospholipase A2 reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 40:376-387.
106. Nalbantoglu J, Tirado-Santiago G, Lahsaini A, Poirier J, Goncalves O, Verge G, Momoli F, Welner SA, Massicotte G, Julien JP, Shapiro ML. 1997. Impaired learning and LTP in mice expressing the carboxyl terminus of the Alzheimer amyloid precursor protein. Nature 387:500-505.
107. Nalivaeva NN, Fisk L, Kochkina EG, Plesneva SA, Zhuravin IA, Babusikova E, Dobrota D, Turner AJ. 2004. Effect of hypoxia/ ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes. Ann NYAcad Sci 1035:21-33.
108. Nawashiro H, Matin D, Hallenbeck JM. 1997. Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res 778:265-271.
109. Nihashi T, Inao S, Kajita Y, Kawai T, Sugimoto T, Niwa M, Kabeya R, Hata N, Hayashi S, Yoshida J. 2001. Expression and distribution of beta amyloid precursor protein and beta amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion. Acta Neurochir 143:287-295.
110. Nishio M, Kohmura E, Yuguchi T, Nakajima Y, Fujinaka T, Akiyama C, Iwata A, Yoshimine T. 2003. Neuronal apolipoprotein E is not synthesized in neuron after focal ischemia in rat brain. Neurol Res 25:390-394.
111. Nita DA, Nita V, Spulber S, Moldovan M, Popa DP, Zagrean AM, Zagrean L. 2001. Oxidative damage following cerebral ischemia depends on reperfusion-a biochemical study in rat. J Cell Mol Med 5:163-170.
112. Nitatori T, Sato N, Waguri S, Karasawa Y, Araki H, Shibanai K, Kominami E, Uchiyama Y. 1995. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 15:1001-1011.
113. Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, Laferla FM. 2006. Temporal profile of amyloid-beta A beta oligomerization in an in vivo model of Alzheimer disease-a link between A beta and tau pathology. J Biol Chem 281:1599-1604.
114. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. 2006. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 26:654-665.
115. Ooboshi H, Ibayashi S, Takada J, Kumai Y, Iida M. 2003. Brain ischemia as a potential target of gene therapy. Exp Gerontol 38:183-187.
116. Orzylowska O, Oderfeld-Nowak B, Zaremba M, Januszewski S, Mossakowski MJ. 1999. Prolonged and concomitant induction of astroglial immunoreactivity of interleukin-1 beta and interleukin-6 in the rat hippocampus after transient global ischemia. Neurosci Lett 263:72-76.
117. Oster-Granite ML, McPhie DL, Greenan J, Neve RL. 1996. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J Neurosci 16:6732-6741.
118. Palacios G, Mengod G, Tortosa A, Ferrer I, Palacios JM. 1995. Increased β-amyloid precursor protein expression in astrocytes in the gerbil hippocampus following ischaemia: association with proliferation of astrocytes. Eur J Neurosci 7:501-510.
119. Papadopoulos MC, Giffard RG, Bell BA. 2000. An introduction to the changes in gene expression that occur after cerebral ischaemia. Br J Neurosurg 14:305-312.
120. Pasquier F, Leys D. 1997. Why are stroke patients prone to develop dementia? J Neurol 244:135-142.
121. Pekny M, Nilsson M. 2005. Astrocyte activation and reactive gliosis. Glia 50:427-434.
122. Pennypacker KR, Hernandez H, Benkovic S, Morgan DG, Willing AE, Sanberg PR. 1999. Induction of presenilins in the rat brain after middle cerebral arterial occlusion. Brain Res Bull 48: 539-543.
123. Petito C, Morgello S, Felix JC, Lesser ML. 1990. The two patterns of reactive astrocytosis in postischemic rat brain. J Cereb Blood Flow Metab 10:850-859.
124. Pfefferkorn T, Rosenberg GA. 2003. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 34:2025-2030.
125. Pinteaux E, Rothwell NJ, Boutin H. 2006. Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 53:551-556.
126. Pluta R. 2000. The role of apolipoprotein E in the deposition of β-amyloid peptide during ischemia-reperfusion brain injury. A model of early Alzheimer's disease. Ann NY Acad Sci 903: 324-334.
127. Pluta R. 2001. Proteins associated with Alzheimer's disease in conditions predisposing to Alzheimer's-type neurodegeneration. J Cereb Blood Flow Metab 21(Suppl 1):S424.
128. Pluta R. 2002a. Glial expression of the β-amyloid peptide in cardiac arrest. J Neurol Sci 203-204:277-280.
129. Pluta R. 2002b. Astroglial expression of the beta-amyloid in ischemia-reperfusion brain injury. Ann NY Acad Sci 977:102-108.
130. Pluta R. 2003. Blood-brain barrier dysfunction and amyloid precursor protein accumulation in microvascular compartment following ischemia-reperfusion brain injury with 1-year survival. Acta Neurochir Suppl 86:117-122.
131. Pluta R. 2004. From brain ischemia-reperfusion injury to possible sporadic Alzheimer's disease. Curr Neurovasc Res 1:441-453.
132. Pluta R. 2006. Ischemia-reperfusion factors in sporadic Alzheimer's disease. In: Welsh EM, editor. New Research on Alzheimer's disease. New York: Nova Science Publishers. p 183-234.
133. Pluta R. 2007. Ischemia-reperfusion pathways in Alzheimer's disease. New York: Nova Science Publishers.
134. Pluta R, Barcikowska M, Debicki G, Ryba M, Januszewski S. 1997a. Changes in amyloid precursor protein and apolipoprotein E immunoreactivity following ischemic brain injury in rat with long-term survival: influence of idebenone treatment. Neurosci Lett 232:95-98.
135. Pluta R, Barcikowska M, Januszewski S, Misicka A, Lipkowski AW. 1996. Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's β-amyloid- (1-42)-peptide. Neuro-Report 7:1261-1265.
136. Pluta R, Barcikowska M, Mossakowski MJ, Zelman I. 1997b. Betaamyloid peptide and C-terminal of beta-amyloid precursor protein persist for over 1 year in rat brain after global ischemia. J Cereb Blood Flow Metab 17(Suppl 1):S775.
137. Pluta R, Barcikowska M, Mossakowski MJ, Zelman I. 1998. Cerebral accumulation of beta-amyloid following ischemic brain injury with long-term survival. Acta Neurochir Suppl 71:206-208.
138. Pluta R, Barcikowska M, Misicka A, Lipkowski AW, Spisacka S, Januszewski S. 1999. Ischemic rats as a model in the study of the neurobiological role of human β-amyloid peptide. Time-dependent disappearing diffuse amyloid plaques in brain. NeuroReport 10:3615-3619.
139. Pluta R, Januszewski S, Ulamek M. 2008. Ischemic blood-brain barrier and amyloid in white matter as etiological factors in leukoaraiosis. Acta Neurochir Suppl 102:353-356.
140. Pluta R, Kida E, Golabek AA, Mossakowski MJ. 1995a. Accumulation of Alzheimer's β-amyloid associated proteins: apolipoproteins E, J and A-1 in rat brain after global cerebral ischemia. J Cereb Blood Flow Metab 15(Suppl 1):S227.
141. Pluta R, Kida E, Golabek AA, Mossakowski MJ. 1995b. Apolipoproteins E and J in rat ischemic brain: colocalization with amyloid protein precursor. Eur J Neurosci Suppl 8:170.
142. Pluta R, Kida E, Lossinsky AS, Golabek AA, Mossakowski MJ, Wisniewski HM. 1994a. Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer's β-amyloid protein precursor in the brain. Brain Res 649:323-328.
143. Pluta R, Lossinsky AS, Mossakowski MJ, Faso L, Wisniewski HM. 1991. Reassessment of new model of complete cerebral ischemia in rats. Method of induction of clinical death, pathophysiology and cerebrovascular pathology. Acta Neuropathol 83:1-11.
144. Pluta R, Lossinsky AS, Wisniewski HM, Mossakowski MJ. 1994b. Early blood-brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest. Brain Res 633:41-52.
145. Pluta R, Misicka A, Barcikowska M, Spisacka S, Lipkowski AW, Januszewski S. 2000. Possible reverse transport of β-amyloid peptide across the blood-brain barrier. Acta Neurochir Suppl 76:73-77.
146. Pluta R, Salinska E, Puka M, Stafiej A, Lazarewicz JW. 1988. Early changes in extracellular amino acids and calcium concentrations in rabbit hippocampus following complete 15-min cerebral ischemia. Resuscitation 16:193-210.
147. Pluta R, Ulamek M, Januszewski S. 2006. Micro-blood-brain barrier openings and cytotoxic fragments of amyloid precursor protein accumulation in white matter after ischemic brain injury in longlived rats. Acta Neurochir Suppl 96:267-271.
148. Polavarapu R, An J, Zhang C, Yepes M. 2008. Regulated intramembrane proteolysis of the low-density lipoprotein receptor-related protein mediates ischemic cell death. Am J Pathol 172:1355-1362.
149. Popa-Wagner A. 2007. Alzheimer's disease pathological factors in ischemic aged brain. In: Pluta R, editor. Ischemia-reperfusion pathways in Alzheimer's disease. New York: Nova Science Publishers. p 51-84.
150. Pulsinelli WA, Brierley JB, Plum F. 1982. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11:491-498.
151. Qi J, Wu H, Yang Y, Wand D, Chen Y, Gu Y, Liu T. 2007. Cerebral ischemia and Alzheimer's disease: the expression of amyloid-β and apolipoprotein E in human hippocampus. J Alzheimer's Dis 12:335-341.
152. Rathmell JC, Thompson CB. 1999. The central effectors of cell death in the immune system. Annu Rev Immunol 17:781-828.
153. Read SJ, Parsons AA, Harrison DC, Philpott K, Kabnick K, O'Brien S, Clark S, Brawner M, Bates S, Gloger I, Legos JJ, Barone FC. 2001. Stroke genomics: approaches to identify, validate, and understand ischemic stroke gene expression. J Cereb Blood Flow Metab 21:755-778.
154. Rogers JT, Leiter LM, McPhee J, Cahill CM, Zhan SS, Potter H, Nilsson LN. 1999. Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 50-untranslated region sequences. J Biol Chem 274:6421-6431.
155. Roof RL, Schielke GP, Ren X, Hall ED. 2001. A comparison of longterm functional outcome after 2 middle cerebral artery occlusion models in rats. Stroke 32:2648-2657.
156. Rosenbaum DM, Gupta G, D'Amore J, Sinhg M, Weidenheim K, Zhang H, Kessler JA. 2000. Fas(CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. J Neurosci Res 61:686-692.
157. Rosenberg GA, Cunningham LA, Wallace J, Alexander S, Estrada EY, Grossetete M, Razhagi A, Miller K, Gearing A. 2001. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893:104-112.
158. Rossner S, Lange-Dohna C, Zeitschel U, Perez-Polo JR. 2005. Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme. J Neurochem 92:226-234.
159. Sanchez-Moreno C, Dashe JF, Scott T, Thaler D, Folstein MF, Martin A. 2004. Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 35:163-168.
160. Sastre M, Dewachter I, Landreth GE, Willson TM, Klockgether T, Van Leuven
161. Schmidt-Kastner R, Szymas J, Hossmann KA. 1990. Immunohistochemical study of glial reaction and serum-protein extravasation in relation to neuronal damage in rat hippocampus after ischemia. Neuroscience 38:527-540.
162. Shackelford DA, Yeh RY. 1998. Dephosphorylation of tau during transient forebrain ischemia in the rat. Mol Chem Neuropathol 34:103-120.
163. Sharp RF, Lu A, Tang Y, Millhorn DE. 2000. Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab 20:1011-1032.
164. Shi J, Panickar KS, Yang S-H, Rabbani O, Day AL, Simpkins JW. 1998. Estrogen attenuates over-expression of β-amyloid precursor protein messenger RNA in an animal model of focal ischemia. Brain Res 810:87-92.
165. Shi J, Yang SH, Stubley L, Day AL, Simpkins JW. 2000. Hypoperfusion induces overexpression of β-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 853:1-4.
166. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S. 2006. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49:489-502.
167. Sinigaglia-Coimbra R, Cavalheiro EA, Coimbra CG. 2002. Postischemic hypertermia induces Alzheimer-like pathology in the rat brain. Acta Neuropathol 103:444-452.
168. Smith ML, Auer RN, SiesjöBK. 1984. The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol 64:319-332.
169. Soriano SG, Amaravadi LS, Wang YF, Zhou H, Yu GX, Tonra JR, Fairchild-Huntress V, Fang Q, Dunmore JH, Huszar D, Pan Y. 2002. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol 125:59-65.
170. Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, Van Rooijen N, Andjelkovic AV. 2005. Monocyte chemoattractant protein-protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab 25:593-606.
171. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. 2002. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156:1051-1063.
172. Sugawara T, Fujimura M, Morita-Fujimura Y, Kawase M, Chan PH. 1999. Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampus CA1 neurons in rats after transient global cerebral ischemia. J Neurosci 19: RC39:1-6.
173. Sugawara T, Fujimura M, Noshita N, Kim GW, Saito A, Hayashi T, Narasimhan P, Maier CM, Chan PH. 2004. Neuronal death/ survival signaling pathways in cerebral ischemia. NeuroRx 1: 17-25.
174. Takada J, Ooboshi H, Ago T, Kitazono T, Yao H, Kadomatsu K, Muramatsu T, Ibayashi S, Iida M. 2005. Postischemic gene transfer of midkine, a neurotrophic factor, protects against focal brain ischemia. Gene Ther 12:487-493.
175. Takuma K, Baba A, Matsuda T. 2004. Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 72:111-127.
176. Tanimukai H, Imaizumi K, Kudo T, Katayama T, Tsuda M, Takagi T, Tohyama M, Takeda M. 1998. Alzheimer-associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia. Mol Brain Res 54:212-218.
177. Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo A, Beltramo M. 2002. Expression of fractalkine and its receptor, CX3CR1, in response to ischemia-reperfusion brain injury in the rat. Eur J Neurosci 15:1663-1668.
178. Tatemichi TK, Foulkes MA, Mohr JP, Hewitt JR, Hier DB, Price TR, Wolf PA. 1990. Dementia in stroke survivors in the stroke data bank cohort: prevalence, incidence, risk factors and computed tomographic findings. Stroke 21:858-866.
179. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. 1996. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380:168-171.
180. Thorvaldsen P, Kuulasmaa K, Rajakangas AM, Rastenyte D, Sarti C, Wilhelmsen L. 1997. Stroke trends in the WHO MONICA project. Stroke 28:500-506.
181. Tomimoto H, Akiguchi I, Wakita H, Nakamura S, Kimura J. 1995. Ultrastructural localization of amyloid protein precursor in the normal and postischemic gerbil brain. Brain Res 672: 187-195.
182. Touzani O, Boutin H, LeFeuvre R, Parker L, Miller A, Luheshi G, Rothwell N. 2002. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci 22:38-43.
183. Tsujimoto Y, Shimizu S. 2005. Another way to die: autophagic programmed cell death. Cell Death Differ 12:1528-1534.
184. Uchihara T, Nakamura A, Arai T, Ikeda K, Tsuchiya K. 2004. Microglial tau undergoes phosphorylation-independent modification after ischemia. Glia 45:180-187.
185. Unal-Cevik I, Kilinc M, Can A, Gursoy-Ozdemir Y, Dalkara T. 2004. Apoptotic and necrotic death mechanisms are concomitantly activated in the same cell after cerebral ischemia. Stroke 35:2189-2194.
186. Uno H, Matsuyama T, Akita H, Nishimura H, Sugita M. 1997. Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab 17:491-499.
187. Van Beek J, Chan P, Bernaudin M, Petit E, MacKenzie ET, Fontaine M. 2000. Glial responses, clusterin, and complement in permanent focal cerebral ischemia in the mouse. Glia 31:39-50.
188. Van Groen T, Puurunen K, Maki HM, Sivenius J, Jolkkonen J. 2005. Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke 36:1551-1556.
189. Walton M, Young D, Sirimanne E, Dodd J, Christie D, Williams C, Gluckman P, Dragunow M. 1996. Induction of clusterin in the immature brain following a hypoxic-ischemic injury. Mol Brain Res 39:137-152.
190. Wang Q, Tang XN, Yenari MA. 2007. The inflammatory response in stroke. J Neuroimmunol 184:53-68.
191. Wen Y, Onyewuchi O, Yang S, Liu R, Simpkins JW. 2004a. Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res 1009:1-8.
192. Wen Y, Yang S, Liu R, Simpkins JW. 2004b. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res 1022:30-38.
193. Wen Y, Yang S, Liu R, Brun-Zinkernagel AM, Koulen P, Simpkins JW. 2004c. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. J Biol Chem 279:22684-22692.
194. Wen Y, Yang SH, Liu R, Perez EJ, Brun-Ziukemagel AM, Koulen P, Simpkins JW. 2007. Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta 1772:473-483.
195. Wisniewski HM, Maslinska D. 1996. Beta-protein immunoreactivity in the human brain after cardiac arrest. Folia Neuropathol 34:65-71.
196. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J. 2003. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9:453-457.
197. Xia CF, Yin H, Borlongan CV, Chao L, Chao J. 2004. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension 43:452-459.
198. Yam PS, Takasago T, Dewar D, Graham DI, McCulloch J. 1997. Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion. Brain Res 760:150-157.
199. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. 1995. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26:676-680.
200. Yan FL, Zhang J, Guan XN, Hong Z. 2007. mRNA expression and activity of ADAM17 in hippocampus after chronic cerebral hypoperfusion: experiment with aged rats. Zhonghua Yi Xue Za Zhi 87:2515-2517.
201. Yang GY, Gong C, Qin Z, Ye W, Mao Y, Bertz AL. 1998. Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. NeuroReport 9:2131-2134.
202. Yang SH, Perez E, Cutright J, Liu R, He Z, Day AL, Simpkins JW. 2002. Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. J Appl Physiol 92:195-201.
203. Yang Y, Kinney GA, Spain WJ, Breitner JCS, Cook DG. 2004. Presenilin-1 and intracellular calcium stores regulate neuronal glutamate uptake. J Neurochem 88:1361-1372.
204. Yang SH, Simpkins JW. 2007. Ischemia-reperfusion promotes tau and beta-amyloid pathology and a progressive cognictive impairment. In: Pluta R, editor. Ischemia-reperfusion pathways in Alzheimer's disease. New York: Nova Science Publishers, Inc. p 113-138.
205. Yenari MA, Xu L, Tang XN, Qiao Y, Giffard RG. 2006. Microglia potentate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 37:1087-1093.
206. Yepes M, Brown SA, Moore EG, Smitj EP, Lawrence DA, Winkles JA. 2005. A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. Am J Pathol 166:511-520.
207. Yokota M, Saido TC, Tani E, Yamaura I, Minami N. 1996. Cytotoxic fragment of amyloid precursor protein accumulates in hippocampus after global forebrain ischemia. J Cereb Blood Flow Metab 16:1219-1223.
208. Yu YM, Kim JB, Lee KW, Kim SY, Han PL, Lee JK. 2005. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke 36:2238-2243.
209. Zhang N, Komine-Kobayashi M, Tanaka R, Liu M, Mizuno Y, Urabe T. 2005. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36:2220-2225.
210. Zhao H, Yenari MA, Cheng D, Barreto-Chang OL, Sapolsky RM, Steinberg GK. 2004. Bcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the rat. J Cereb Blood Flow Metab 24:681-692.
211. Zheng Z, Yenari MA. 2004. Post-ischemic inflammation: molecular mechanisms and therapeutions implications. Neurol Res 26: 884-892.
212. Zhu C, Xu F, Wang X, Shibata M, Uchiyama Y, Blomgren K, Hgberg H. 2006. Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischemia. J Neurochem 96:1016-1027.